Literature DB >> 1430261

Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards.

S P Parker1, W D Cubitt.   

Abstract

AIMS: To determine whether the Eiken particle agglutination test could be modified to make it sufficiently sensitive to screen blood samples collected on Guthrie cards for the presence of antibodies to Toxoplasma gondii; to evaluate the specificity of the modified system; and to compare seroepidemiological data on the prevalence of T gondii in pregnant women.
METHODS: Simulated dried blood spots were prepared from sera from pregnant women booking for antenatal care. Eluates from the simulated dried blood spot cards and sera were tested in parallel using the modified test (1 in 5 dilution of latex) and the standard assay (neat latex particles) and endpoints determined. Guthrie card eluates, from neonates in three Thames regions, were then tested using the modified test.
RESULTS: The modified test produced a 4.21-fold increase in antibody titre in 85 sera when tested in parallel with the standard test. Eluates of 168/170 from simulated dried blood spots derived from seropositive patients gave a positive result in the modified test. The two eluates which gave a negative result were derived from patients with an equivocal titre of 1/16 in the standard serum test. Of the eluates derived from serum negative patients all 103 were negative at a dilution of 1 in 4 in the modified test. The seroprevalence of antibodies to T gondii in pregnancy was 21.8% using the standard test. A similar value of 20.5% was obtained when dried blood spots from neonates in a similar region of London were tested by the modified test.
CONCLUSIONS: The modified Eiken Toxo-reagent test is sensitive, simple, and economic for screening large numbers of dried blood spots. The procedure could be easily semiautomated and the technique applied to the mass screening of neonatal blood samples collected on Guthrie cards to determine the seroprevalence of T gondii in pregnant women.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430261      PMCID: PMC495064          DOI: 10.1136/jcp.45.10.907

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii.

Authors:  W D Cubitt; A E Ades; C S Peckham
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Gelatin particle agglutination assay for HIV antibodies: a rapid, economical modification with increased sensitivity.

Authors:  J A Barbara; R Salker; P Challis; M Contreras
Journal:  Med Lab Sci       Date:  1989-04

3.  Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study.

Authors:  M Lappalainen; P Koskela; K Hedman; K Teramo; P Ammälä; V Hiilesmaa; M Koskiniemi
Journal:  Scand J Infect Dis       Date:  1992

4.  Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii.

Authors:  J Johnson; K Duffy; L New; R E Holliman; B S Chessum; D G Fleck
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

5.  Toxoplasmosis in pregnancy and its transmission to the fetus.

Authors:  G Desmonts; J Couvreur
Journal:  Bull N Y Acad Med       Date:  1974-02

6.  Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing.

Authors:  A E Ades; S Parker; T Berry; F J Holland; C F Davison; D Cubitt; M Hjelm; A H Wilcox; C N Hudson; M Briggs
Journal:  Lancet       Date:  1991-06-29       Impact factor: 79.321

7.  Comparative study of three tests (dye test, indirect haemagglutination test, latex agglutination test) for the detection of antibodies to Toxoplasma gondii in human sera.

Authors:  A H Balfour; D G Fleck; H P Hughes; D Sharp
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

8.  Longitudinal study of Toxoplasma seroprevalence in South Yorkshire.

Authors:  J Walker; D J Nokes; R Jennings
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

9.  Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection.

Authors:  J van der Veen; M F Polak
Journal:  J Hyg (Lond)       Date:  1980-10

10.  Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies.

Authors:  C S Peckham; R S Tedder; M Briggs; A E Ades; M Hjelm; A H Wilcox; N Parra-Mejia; C O'Connor
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

View more
  5 in total

Review 1.  The use of the dried blood spot sample in epidemiological studies.

Authors:  S P Parker; W D Cubitt
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Community study of toxoplasma antibodies in urban and rural schoolchildren aged 4 to 18 years.

Authors:  M R Taylor; B Lennon; C V Holland; M Cafferkey
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

3.  Validation of dried blood spots in monitoring toxoplasmosis.

Authors:  Mamdouh M Hegazy; Mona K Hegazy; Manar S Azab; Nairmen Nabih
Journal:  Pathog Glob Health       Date:  2020-05-18       Impact factor: 2.894

4.  Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis.

Authors:  A E Ades; S Parker; R Gilbert; P A Tookey; T Berry; M Hjelm; A H Wilcox; D Cubitt; C S Peckham
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

Review 5.  An overview of the clinical use of filter paper in the diagnosis of tropical diseases.

Authors:  Pieter W Smit; Ivo Elliott; Rosanna W Peeling; David Mabey; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2013-12-23       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.